Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$4.87−0.50 (-9.31%)
Close on Nov 13, 2026Market cap $306.04MP/E –Yield –
Cytosorbents total assets
Total assets on the balance sheet at the end of each period.
Cytosorbents's total assets was $37.96M at Jun 30, 2026. For fiscal 2025 it was $44.18M, down 6.7% from the year before. Over ten years it grew 14.7% a year on average. The highest annual figure on record is $89.95M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.18M | -6.7% |
| FY2024 | Dec 31, 2024 | $47.37M | -10.5% |
| FY2023 | Dec 31, 2023 | $52.96M | -16.3% |
| FY2022 | Dec 31, 2022 | $63.23M | -29.4% |
| FY2021 | Dec 31, 2021 | $89.52M | -0.5% |
| FY2020 | Dec 31, 2020 | $89.95M | +228.5% |
| FY2019 | Dec 31, 2019 | $27.38M | -19.9% |
| FY2018 | Dec 31, 2018 | $34.20M | +41.9% |
| FY2017 | Dec 31, 2017 | $24.10M | +148.6% |
| FY2016 | Dec 31, 2016 | $9.69M | -13.9% |
| FY2015 | Dec 31, 2015 | $11.25M | +32.9% |
| FY2014 | Dec 31, 2014 | $8.47M | +109.3% |
| FY2013 | Dec 31, 2013 | $4.05M | +21.2% |
| FY2012 | Dec 31, 2012 | $3.34M | +57.3% |
| FY2011 | Dec 31, 2011 | $2.12M | +17.1% |
| FY2010 | Dec 31, 2010 | $1.81M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $37.96M | -20.9% |
| Q1 FY2026 | Mar 31, 2026 | $40.56M | -20.1% |
| Q4 FY2025 | Dec 31, 2025 | $44.18M | -6.7% |
| Q3 FY2025 | Sep 30, 2025 | $45.75M | -4.3% |
| Q2 FY2025 | Jun 30, 2025 | $47.99M | -10.2% |
| Q1 FY2025 | Mar 31, 2025 | $50.78M | +7.9% |
| Q4 FY2024 | Dec 31, 2024 | $47.37M | -10.5% |
| Q3 FY2024 | Sep 30, 2024 | $47.80M | +0.5% |
| Q2 FY2024 | Jun 30, 2024 | $53.43M | +1.9% |
| Q1 FY2024 | Mar 31, 2024 | $47.07M | -18.1% |
| Q4 FY2023 | Dec 31, 2023 | $52.96M | -16.3% |
| Q3 FY2023 | Sep 30, 2023 | $47.58M | -23.6% |
| Q2 FY2023 | Jun 30, 2023 | $52.44M | -26.3% |
| Q1 FY2023 | Mar 31, 2023 | $57.46M | -31.0% |
| Q4 FY2022 | Dec 31, 2022 | $63.23M | -29.4% |
| Q3 FY2022 | Sep 30, 2022 | $62.27M | -34.5% |
| Q2 FY2022 | Jun 30, 2022 | $71.21M | -27.5% |
| Q1 FY2022 | Mar 31, 2022 | $83.27M | -4.8% |
| Q4 FY2021 | Dec 31, 2021 | $89.52M | -0.5% |
| Q3 FY2021 | Sep 30, 2021 | $95.07M | -8.8% |
| Q2 FY2021 | Jun 30, 2021 | $98.19M | +99.3% |
| Q1 FY2021 | Mar 31, 2021 | $87.48M | +97.8% |
| Q4 FY2020 | Dec 31, 2020 | $89.95M | +228.5% |
| Q3 FY2020 | Sep 30, 2020 | $104.28M | +263.6% |
| Q2 FY2020 | Jun 30, 2020 | $49.26M | +72.9% |
| Q1 FY2020 | Mar 31, 2020 | $44.23M | +42.7% |
| Q4 FY2019 | Dec 31, 2019 | $27.38M | -19.9% |
| Q3 FY2019 | Sep 30, 2019 | $28.68M | -16.3% |
| Q2 FY2019 | Jun 30, 2019 | $28.48M | -18.5% |
| Q1 FY2019 | Mar 31, 2019 | $30.99M | +9.5% |
| Q4 FY2018 | Dec 31, 2018 | $34.20M | +41.9% |
| Q3 FY2018 | Sep 30, 2018 | $34.25M | +54.1% |
| Q2 FY2018 | Jun 30, 2018 | $34.95M | +58.2% |
| Q1 FY2018 | Mar 31, 2018 | $28.30M | +241.4% |
| Q4 FY2017 | Dec 31, 2017 | $24.10M | +148.6% |
| Q3 FY2017 | Sep 30, 2017 | $22.22M | +104.6% |
| Q2 FY2017 | Jun 30, 2017 | $22.09M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.29M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.69M | – |
| Q3 FY2016 | Sep 30, 2016 | $10.86M | – |
See a number that looks wrong?